Evidence Working Group
Mission Statement
The mission of the Evidence Working Group is to Monitor and promote awareness of the evidence to support genomic
medicine
Co-Chairs
Marc Abramowicz (Belgium) and Fahd Al-Mulla (Kuwait)
- Overview
- Activities
- Publications
- Get Involved
- Define criteria for evidence evaluation (e.g., standard definition of a patient’s outcomes)
- Monitor evidence of clinical utility of genomic medicine. Actively monitor emerging evidence
- Develop a genomic medicine implementation registry for evidence generation
- Develop measures that can be used across the global community for harmonization and interoperability of data (e.g., phenome; genome, missing data) for evidence-generation studies
- Promote awareness about the evidence available to support genomic medicine; promote implementation in low and middle income countries